Lana Shaiba

Dr. Lana Shaiba

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 May 2021 in Frontiers in Pediatrics
Verified
Journal Article
Open access
PDF file
LSLana Shaiba
Lana Shaiba
AHAdnan Hadid
Adnan Hadid
KAKhalid A. Altirkawi
Khalid A. Altirkawi
HBHind M. Bakheet
Hind M. Bakheet
AAAminah Mohammed Alherz
Aminah Mohammed Alherz
FAFahad A. Alzamil
Fahad A. Alzamil
Background: Vertical transmission of SARS-CoV-2 is under investigation. A few reports suggest the possibility of SARS-CoV-2 transmission from mothers to their neonates. Most neonates have mild symptoms, but some develop multisystem involvement and shock.Case Presentation: We report two cases of possible SARS-CoV-2 vertical transmission from mothers to their neonates. The first case shows maternal infection with SARS-CoV-2 in the second trimester followed by recurrent infection in the third trimester right before the delivery. The infant demonstrated respiratory distress soon after delivery along with myocardial dysfunction and multi-organ system involvement. The second case shows maternal infection with SARS-COV-2 at the time of delivery with preterm labor secondary to placental abruption, with that delivery resulting in the preterm neonate requiring non-invasive ventilation with multisystem involvement in the context of persistently positive SARS-COV-2 PCR in the neonate. Both neonates were treated with IVIG along with steroids. Both neonates recovered fully and were discharged and allowed to go home.Conclusion: In neonates, COVID-19 usually presents as an asymptomatic or mild illness; some may develop a more severe course. Our two cases, however, demonstrate that multisystem involvement, although rare, is possible. This report also supports the current evidence of possible vertical transmission from mothers to their neonates. This multisystem involvement might be underreported and should be considered in neonates with respiratory distress when born to mothers suffering of COVID-19.Clinical Trial Registration: [KSUMC], identifier [No#98763298].

5 May 2022 in Neonatology
Verified
Journal Article
Open access
PDF file
LSLana Shaiba
Lana Shaiba
KMKiran More
Kiran More
AHAdnan Hadid
Adnan Hadid
RARana Almaghrabi
Rana Almaghrabi
MMMunira Al Marri
Munira Al Marri
PSPrakesh Shah
Prakesh Shah
Introduction: Multisystem inflammatory syndrome in neonates (MIS-N) related to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has increasingly been reported worldwide amid the spread of the SARS-CoV-2 pandemic. Methods: We searched PubMed, EMBASE, and CINAHL and preprint servers (BioRxiv.org and MedRxiv.org) using a specified strategy integrating Medical Subject Headings terms and keywords until October 20, 2021. Our aim was to systematically review demographic profiles, clinical features, laboratory parameters, complications, treatments, and outcomes of neonates with MIS-N. Studies were selected when fulfilling the inclusion criteria. Articles were included if they fulfilled the World Health Organization (WHO), Centers for Disease Control (CDC) definitions of MIS-C, or our proposed definition. Results: Sixteen reports of MIS-N including 47 neonates meeting MIS-N criteria were identified. Presentation included cardiovascular compromise (77%), respiratory involvement (55%), and fever in (36%). Eighty-three percent of patients received steroids, and 76% received immunoglobulin. Respiratory support was provided to 60% of patients and inotropes to 45% of patients. Five (11%) neonates died. Conclusion: The common presentation of MIS-N included cardiorespiratory compromise with the possibility of high mortality. Neonates with MIS-N related to SARS-CoV-2 may be at higher risk of adverse outcomes.

12 July 2021 in Frontiers in Pediatrics
Verified
Journal Article
Open access
LSLana Shaiba
Lana Shaiba
KAKhalid Altirkawi
Khalid Altirkawi
AHAdnan Hadid
Adnan Hadid
SASara Alsubaie
Sara Alsubaie
OAOmar Alharbi
Omar Alharbi
PSPrakesh S. Shah
Prakesh S. Shah
The objective of this study is to describe the clinical presentations, radiological and laboratory findings, and outcomes of COVID-19 disease in infants ≤ 90 days of age at presentation. We conducted a retrospective study of infants in this age group who were found to be SARS-CoV-2 positive. Asymptomatic infants who were identified through routine testing following delivery to COVID-19-positive mothers were excluded. We classified infants according to their presentation: asymptomatic, mildly symptomatic, moderately symptomatic, and severely/critically symptomatic. A total of 36 infants were included. Of them, two were asymptomatic and four had severe/critical presentation. Of the severely symptomatic infants, two were considered as multisystem inflammatory syndrome in children (MIS-C) and there was one death. One infant in the severe symptomatic group presented with cardiac failure, with the possibility of congenital infection. Another infant presented with cardiogenic shock. None of these infants received antiviral medication. The study found that infants ≤ 90 days can present with a severe form of COVID-19 disease. Multisystem inflammatory syndrome in children, although rarely reported in infants, is a possible complication of COVID-19 disease and can be associated with significant morbidity and mortality.

28 July 2021 in Healthcare
Verified
Journal Article
Open access
PDF file
LSLana Shaiba
Lana Shaiba
MAMahdi Alnamnakani
Mahdi Alnamnakani
Mohamad-Hani TemsahMohamad-Hani Temsah
Mohamad-Hani Temsah
NANurah Maziad Alamro
Nurah Maziad Alamro
FAFahad Alsohime
Fahad Alsohime
YAYazed AlRuthia
Yazed AlRuthia
Background: The educational process in different medical schools has been negatively affected by the COVID-19 pandemic worldwide. As a part of the Saudi government’s attempts to contain the spread of the virus, schools’ and universities’ educational activities and face-to-face lectures have been modified to virtual classrooms. The purpose of this study was to explore the perceptions of the faculty and the students of an electronic objective structured clinical examination (E-OSCE) activity that took place during the COVID-19 pandemic in the oldest medical school in Saudi Arabia. Methods: An e-OSCE style examination was designed for the final-year medical students by the pediatrics department, College of Medicine at King Saud University in Riyadh, Saudi Arabia. The examination was administered by Zoom™ video conferencing where both students and faculty participated through their laptop or desktop computers. In order to explore the students’ and the faculty’s perceptions about this experience, a newly designed 13-item online questionnaire was administered at the end of the e-OSCE. Results: Out of 136 participants (23 faculty and 112 students), 73 respondents (e.g., 54% response rate) filled out the questionnaire. Most of the respondents (69.8%) were very comfortable with this new virtual experience. Most participants (53.4%) preferred the e-OSCE compared to the classic face-to-face clinical OSCE during the pandemic. Regarding the e-OSCE assessment student tool, 46.6% reported that it is similar to the classic face-to-face OSCE; however, 38.4% felt it was worse. Conclusions: The e-OSCE can be a very effective alternative to the classic face-to-face OSCE due to the current circumstances that still pose a significant risk of infection transmission. Future studies should examine different virtual strategies to ensure effective OSCE delivery from the perspective of both faculty and students.

9 July 2026 in Frontiers in Pediatrics
Verified
Journal Article
Open access
PDF file
LSLana Shaiba
Lana Shaiba
AHAdnan Hadid
Adnan Hadid
KAKhalid Almoosa
Khalid Almoosa
AAAbdulmalik Alharbi
Abdulmalik Alharbi
KAKhalid Alharbi
Khalid Alharbi
BSBadr Sobaih
Badr Sobaih
Background: Very low birth weight (VLBW) infants remain at high risk of mortality and major morbidity, yet longitudinal data from Saudi Arabia spanning several decades are scarce. We examined 25-year trends in survival and morbidity at a single tertiary centre, with particular attention to whether patterns reflect evolving case-mix at the limits of viability. Methods: This retrospective cohort study included inborn VLBW infants (birth weight <1,500 g, gestational age <33 weeks) admitted to the NICU of King Saud University Medical City, Riyadh, across three periods: 1999–2007 ( n = 468), 2011–2018 ( n = 512), and 2019–2024 ( n = 396). Infants <22 weeks’ gestation or with lethal congenital anomalies were excluded. The primary outcome was survival to hospital discharge. Secondary outcomes were respiratory distress syndrome, bronchopulmonary dysplasia, patent ductus arteriosus, intraventricular haemorrhage, periventricular leukomalacia, necrotising enterocolitis, retinopathy of prematurity, and culture-proven sepsis. Categorical variables were compared using chi-square or Fisher's exact tests, continuous variables with ANOVA or Kruskal–Wallis tests. Multivariable regression was precluded by aggregate historical data; a sensitivity analysis restricted to infants ≥24 weeks examined case-mix effects. Results: Crude survival declined significantly across periods (88.7%, 84.0%, 79.0%; p = 0.001). However, among infants ≥24 weeks, survival was 90.0%, 85.8%, and 83.6%, indicating the overall decline is largely driven by increasingly admitted infants at 22–24 weeks. Survival at 23 weeks fell from 61.0% to 6.3%, while survival at 27–31 weeks remained above 80% without significant change. Morbidity improvements were substantial: early-onset sepsis fell from 11.0% to 2.3%, late-onset sepsis from 37.2% to 17.2%, necrotising enterocolitis from 15.6% to 9.3%, and severe retinopathy requiring treatment from 34.5% to 6.3% (all p < 0.001). Respiratory distress syndrome prevalence rose to 99.5%, while surfactant and postnatal corticosteroid use declined. Pneumothorax increased from 5.0% to 10.4% and periventricular leukomalacia from 1.3% to 6.6%; severe intraventricular haemorrhage remained unchanged. Conclusion: Expanding active resuscitation at 22–24 weeks generated an apparent decline in crude survival, while care quality markedly improved, evidenced by large reductions in sepsis, necrotising enterocolitis, and severe retinopathy. Caution is warranted in attributing the decline in crude survival solely to the change in resuscitation policy at 22–24 weeks, as evolving clinical management strategies and other policy changes over the study period may also have contributed to the observed outcomes. Standardised national benchmarking and multicentre surveillance are needed.

13 March 2022 in The Journal of Maternal-Fetal & Neonatal Medicine
Verified
Journal Article
Closed access
RARana Almaghrabi
Rana Almaghrabi
LSLana Shaiba
Lana Shaiba
IBInas Babic
Inas Babic
MAMona Abdelbaky
Mona Abdelbaky
SASana Ibrahim Aljuhani
Sana Ibrahim Aljuhani
FAFahad Alzamil
Fahad Alzamil
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is highly contagious with various possible routes of transmission, resulting in high mortality globally. Controversy exists regarding th...